Skip to main content
. Author manuscript; available in PMC: 2014 Nov 5.
Published in final edited form as: Cancer Causes Control. 2014 Jul 22;25(10):1379–1386. doi: 10.1007/s10552-014-0443-x

Figure 2.

Figure 2

Kaplan–Meier curve for melanoma-specific survival among melanoma patients, according to mutation status of BRAFV600E and NRASQ61R. Red line: survival for patients with BRAFV600E mutation; green line: survival for patients with NRASQ61R mutation; and black line: survival for patients with wild-type at both loci.